Advertisement

Topics

Investor support spurs progress at Stamford biotechs

11:49 EDT 6 Aug 2017 | Topix

Loxo Oncology CEO Joshua Bilenker, center, and Chief Business Officer Jacob Van Naarden pose for a photo inside Loxo's Tresser Boulevard offices, in downtown Stamford, on Tuesday, July 18, 2017. Loxo Oncology CEO Joshua Bilenker, center, and Chief Business Officer Jacob Van Naarden pose for a photo inside Loxo's Tresser Boulevard offices, in downtown Stamford, on Tuesday, July 18, 2017.

Original Article: Investor support spurs progress at Stamford biotechs

NEXT ARTICLE

More From BioPortfolio on "Investor support spurs progress at Stamford biotechs"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...